Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial. - Wikidata - wikimedia - TriplyDB

Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.

Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.

http://www.wikidata.org/entity/Q35693638

about

Nicotine receptor partial agonists for smoking cessation Attitudes and interest in technology-based treatment and the remote monitoring of smoking among adolescents and emerging adults.Update of Adolescent Smoking Cessation Interventions: 2009-2014 Emerging Pharmacologic Treatments for Adolescent Substance Use: Challenges and New Directions.A double-blind placebo-controlled randomized trial of varenicline for smokeless tobacco dependence in India Pharmacotherapy for Substance Use Disorders in Youths.The Role of Pharmacotherapy in the Treatment of Adolescent Substance Use Disorders Zonisamide Reduces Withdrawal Symptoms But Does Not Enhance Varenicline-Induced Smoking Cessation.Sex Differences in Varenicline Efficacy for Smoking Cessation: A Meta-Analysis.Up in smoke? A preliminary open-label trial of nicotine replacement therapy and cognitive behavioral motivational enhancement for smoking cessation among youth in Los Angeles.Tobacco cessation interventions for young people.Varenicline and Nicotine Patch Therapies in Young Adults Motivated to Quit Smoking: A Randomized, Placebo-controlled, Prospective Study.A comparison of neuropsychiatric adverse events during early treatment with varenicline or a nicotine patch.Cigarette smoking and onset of mood and anxiety disorders.

P2860

Q24185773-BB8B0F11-A6E8-461E-BB54-09A5DC2C4ECE Q33752175-D2AF7119-7F36-4756-B2EE-F4FB527C7154 Q35966853-BD2CB3D6-FB4F-4F45-ADD4-E1B1F78365F8 Q37200944-F87BAC3B-CE98-4247-942D-893DD55848EB Q37395553-2A28383C-75CF-4122-8D20-DADABD0EC02E Q37574339-EE791278-CFB8-4861-950A-E02018451827 Q38950639-3FA62CB9-610E-42D2-808F-2D8954781F60 Q40420757-D74450C8-A8BA-4C2D-9177-9CB0D839AC77 Q40456297-7853875F-D286-429B-93BA-68E73A9ACE8C Q46803842-8FE36EF3-C4AF-44C5-B2E7-B7216875058F Q47579852-78F52FA7-3147-43FC-8B42-322821903AE5 Q47585574-4E5D5D70-0C71-4890-AFB2-0387C48BCC71 Q48065103-A949E16E-6339-4FA3-AA31-BBE94EEC3C37 Q54968763-BE5047B2-2060-4F73-8BE4-67F3757406BD

P2860

Varenicline versus bupropion XL for smoking cessation in older adolescents: a randomized, double-blind pilot trial.

http://www.wikidata.org/entity/Q35693638

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@ast

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@en

type

label

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@ast

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@en

prefLabel

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@ast

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@en

P1433

Q35693638-1B4B9E31-B615-4630-931A-E77481E84869

P1476

Q35693638-2DBF1DED-6040-418E-B9E5-184D4211B668

P2093

Q35693638-11E65EBA-85AE-4441-AD42-10322736F7EF

Q35693638-49F51FC4-D0EE-49D3-A28E-2DB9EC24EE97

Q35693638-8803E5C0-2806-473C-A10F-F512479DFE11

Q35693638-9B8D063A-C45B-4089-9C43-6523F1107B13

Q35693638-E6BDA325-52F4-4DB8-A724-6EBDAAD0E960

P2860

Q35693638-0364DD7A-13F4-4D3C-B713-1E9F3FB425E7

Q35693638-0C0D62E7-2F6C-48FD-A0B5-3E3E3EE42250

Q35693638-14777BD8-9C4F-46A8-99E3-0D404C547CBA

Q35693638-2696B4AA-1E6E-4A45-B09C-2004E771472B

Q35693638-2B5D41EA-19D1-425E-A924-B1DE9B0CE226

Q35693638-2E15C199-336B-440C-A19F-82003A83160D

Q35693638-32F54B23-0B74-44B7-A501-8D3D9CA28AB2

Q35693638-3543C7FE-C35A-4B84-B209-76CACAD76EA5

Q35693638-50DB7BA1-4631-47C9-B264-EB8B361CF1CC

Q35693638-58549E2E-8D2E-4B94-9BC0-1BA4E8D3E828

P304

Q35693638-0CB3740D-A487-47EB-873F-341650EB3D90

P31

Q35693638-58450300-6BBB-4EDD-8D72-FDE5879A6EF6

P356

Q35693638-4721E6C6-3A78-44EC-B75A-EF16A522E51E

P433

Q35693638-0DD44471-272A-4239-BC8C-48A8247D77ED

P478

Q35693638-02B7724E-557C-4157-823D-4858BE198B9B

P577

Q35693638-E0C8E9D6-A16E-4C0F-99C9-E77A1508DA0F

P5875

Q35693638-82B978E8-0588-4E27-A16A-F4F0D187D92C

P698

Q35693638-C7F3F523-D80A-4C2F-82B9-C771C1F3D285

P921

Q35693638-F58F3639-904D-4F6D-9EDB-C7A4DDA5A232

P932

Q35693638-63D6826D-A229-41A9-917F-AEF6912099A8

P356

P1433

Nicotine and Tobacco Research

P1476

Varenicline versus bupropion X ...... zed, double-blind pilot trial.

@en

P2093

A Lee Lewis

http://www.w3.org/2001/XMLSchema#string

Erin M Klintworth

http://www.w3.org/2001/XMLSchema#string

Himanshu P Upadhyaya

http://www.w3.org/2001/XMLSchema#string

Kevin M Gray

http://www.w3.org/2001/XMLSchema#string

Matthew J Carpenter

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of smoking and smoking abstinence on cognition in adolescent tobacco smokers

The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10

Pharmacotherapies for smoking cessation: a meta-analysis of randomized controlled trials.

Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial.

Bupropion SR and contingency management for adolescent smoking cessation.

Contingency management for attendance to group substance abuse treatment administered by clinicians in community clinics

Adolescent and young adult tobacco prevention and cessation: current status and future directions.

The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence.

Better patient persistence with once-daily bupropion compared with twice-daily bupropion.

Higher magnitude cash payments improve research follow-up rates without increasing drug use or perceived coercion

P304

234-239

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/NTR/NTR130

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2011-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51510647

http://www.w3.org/2001/XMLSchema#string

P698

21778151

http://www.w3.org/2001/XMLSchema#string

P921

P932

3265741

http://www.w3.org/2001/XMLSchema#string